BUB1 and Lipedema: Treatment of both ADSC groups with 2OH-BNPP1 revealed marked reduction of histone H2A phosphorylation at T120 (Fig. 6e, f), a novel and important finding that suggested that the effect of Bub1 in lipedema is mediated by its capacity to phosphorylate downstream targets such as histone H2A.